MedTrace Logo

The Effect of Health Belief Model-Based Cancer Education on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings

NCT06579625 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2024-09-03

No results posted yet for this study

Summary

Participants will be randomly assigned to the experimental and control groups. The study will involve a total of 78 participants, with 39 in the experimental group and 39 in the control group. The 39 participants assigned to the experimental group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales. They will then receive cancer education consisting of four modules, which will be completed over four weeks. At the end of these four weeks, they will complete the scales again. One month after the education, the experimental group will complete the scales once more for follow-up monitoring. The control group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales after agreeing to participate in the study. They will complete the scales again one month later. The evaluation of the education in the experimental group will involve comparing the scales completed before and after the education.

Conditions

  • Cancer
  • Education
  • Caregiver
  • Randomised Controlled Trial

Interventions

OTHER

Cancer education

Participants in the experimental group will receive cancer education.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-10
Primary Completion
2024-10-10
Completion
2024-10-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06579625 on ClinicalTrials.gov